诺唯赞 is a biotechnology company that engages in the research and development of enzymes, antigens, antibodies, and other functional proteins along with high molecular organic materials. The company provides solutions in life sciences, in vitro diagnostics, and biomedicine.

诺唯赞

Vazyme Biotech | 23,381 followers on LinkedIn. A Global Supplier Dedicated to Design, Manufacture and Application of Bioactive Proteins. | Vazyme (688105.SH) is a global technology and service provider that dedicated to the design, manufacture, and application of bioactive proteins and continuously expands the application fields of core technologies in life science, in vitro diagnostics, bio-medicine, and others. To meet the varying needs of our customers and partners, we have developed over 600 types of genetically engineered recombinant enzymes and over 2,500 types of high-performance materials and over 2,000 end products. While remaining steadfast to high quality standards, producing all core materials in-house and adhering to GMP quality control standards, we endeavor to maintain a stable and sufficient supply for global customers by establishing subsidiary companies and local warehouses.

International Business Development, Country Manager (Seoul, South Korea) Drug Discovery, Assay Development and NGS Library Preparation Reagents

Birendra Kumar Singh

CEO at Qingtang Investment Group expertized in the biomedical industry

Hua Xu

Preventing and controlling viral diseases

Dr. Arslan Mehboob_PhD

Director of Europe Marketing Department

Cécile L.

Vazyme Biotech

We may grow up, but we never let go of the little one within us. Life is more beautiful with a touch of childlike wonder! 🎉 Happy #WorldChildrensDay 🎉 Whether you’re looking for the perfect big one or a cute mini one, we’ve got you covered! 🧪🧫 https://bit.ly/3ALpf4E #HappyChildrensDay #science #lab

See our footprint in Thailand! 🌏 🚀 At Vazyme, we believe in the power of connection! Our recent Master qPCR session with Dr. Hang Zhao was a hit, with attendees in Thailand tuning in to learn and share their insights. The presentation covered essential aspects of mastering qPCR, helping address overlooked details and common challenges, all aimed at empowering participants in their scientific journeys. The energy in the room was inspiring, proving that our passion for science knows no bounds! 💬🔍 #biotech #qPCR #Innovation

🎥 #MEDICA 2024 has been a fantastic experience! Check out our highlight video showcasing our time at Booth HALL 3/B46. We had such meaningful conversations and connections with all of you! We look forward to seeing you next year! Until then, stay connected! 🌐 #Healthcare #medical #Biotech #Microfluidics #alzheimersdisease

💬 Day 2 at #MEDICA 2024 is all about connection! Vazyme is thrilled to engage with our customers at Booth HALL 3/B46. Your feedback inspires us, and we’re eager to hear your thoughts! Let’s collaborate for a brighter future in microfluidics. If you’re at the event, drop by for a chat! #Healthcare #medical #Biotech #Microfluidics #alzheimersdisease

🎉 We’re live from #MEDICA 2024 in Germany! Come check out our advanced Logicore System with leading digital microfluidic technology at Booth HALL 3/B46! Come by, say hello, and let’s explore the future of diagnostics together. We can’t wait to meet you! 🐼✨ #Healthcare #medical #Biotech #Microfluidics #alzheimersdisease

🧪 Your Expertise Needed! We want to know: which detection method do you trust for Mycoplasma contamination? Join our poll and share your thoughts! Every vote counts! 🌟 #LifeScience #Biotech #Mycoplasma #quiz

🌐 What a memorable event at the #ASHG Annual Meeting in Denver! Thank you for the engaging discussions! We're always here to assist you in your research and advance the biotech industry together! #lifescience #Biotech #lab #Genetics #Genomics #HumanGenetics #Research

💡Imagine if we could make testing for infectious diseases more convenient and accurate—what would that mean for us? 🌟Vazyme Logicore System is designed for accuracy and efficiency, delivering results in approximately one hour. Don’t miss out on the future of health testing! 🗓️Join us at MEDICA from Nov 11-14 to see it live >> https://bit.ly/3UrfZZZ 🎥 Don’t forget to watch our video! #LifeSciences #Biotech #MEDICA2024 #Microfluidics

🔬 Looking for a reliable solution for RNA extraction? Meet FreeZol Reagent, designed for efficient total RNA extraction with unmatched purity! No chloroform needed, and you can complete your extraction in just 1 hour. 🔗 Check out now>> https://bit.ly/40B3jDY #LifeScience #Biotech #RNAextraction #DNAextraction

🌟 Yes! We are here at #MEDICA ! Visit us at booth HALL 3/B46 to explore our advanced Logicore System with leading digital microfluidic technology in action. Don't miss the opportunity to connect with our team and discover reliable solutions. See you there! 👋✨

CrUX Dataset

CrUX Top 10m

Sales and Support

Dongliang Chen

Project Manager

Jingchao Xi

Account Manager

Kenny Nguyen

Nacky Sheh

Product Manager

Penglin Li

International Marketing Manager

Sittar Li

Business Development Manager

Vivien Han

Vazyme Business Development Manager

Yichao Wang

Jingxin Yao

Cao Lin

Founder, Chairman & Chief Executive Officer

Bo Tang

Co-Founder

Health Diagnostics Companies that Exited

Asia-Pacific (APAC) Companies With Less Than $500M in Revenue (Top 10K)

Asia-Pacific (APAC) Life Science Companies

Asia Companies With More Than 100 Employees (Top 10K)

Vazyme Biotech is devoted to the development and production of enzymes and antibodies. Our products cover clinical diagnosis, molecular diagnostics, high-throughput sequencing and life science research and other related fields. The company is located in the city of Nanjing, china's ancient capital of the Six Dynasties. Vazyme Biotech is in the front of scenic Qixia mountain, dependent on the regional radiation force of the National Economic and Technological Development Zone of Nanjing. With advanced capability of R&D and cutting- edge technology, Vazyme Biotech will create a new pattern of National Biotechnology.

China Life Private Equity Investment

Series C - Vazyme Biotech

China Life Insurance

Series B - Vazyme Biotech

Series A - Vazyme Biotech

Seed Round - Vazyme Biotech

Angel Round - Vazyme Biotech

Nanjing

Jiangsu

China

Asia

Vazyme Biotech on LinkedIn: #eshg #ngs #biotech #lifescience #lab #eshg2024

Asset turnover of NANJING VAZYME BIOTECH – SSE:688105 – TradingView

Total liabilities & shareholders' equities of NANJING VAZYME BIOTECH – SSE:688105 – TradingView

Book value per share of NANJING VAZYME BIOTECH – SSE:688105 – TradingView

Nanjing Vazyme BiotechLtd Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

Post-crotonylation oxidation by a monooxygenase promotes ...

Regulation of fungal raw-starch-degrading enzyme production ...

XAF1 promotes anti-RNA virus immune responses by ...

Screening of immunogenic proteins and evaluation of vaccine ...

Identification of a deep-branching thermophilic clade sheds ...

A qPCR master mix designed for the detection of low-expression genes, offering high sensitivity and specificity for low-abundance and challenging-to-amplify samples.

United States

North America

Indonesia

Turkey

Europe

Philippines

Israel

Nanjing Vazyme Biotech Co., Ltd., a biotechnology company, engages in the research, development, and production of enzymes, antigens, antibodies, and polymer organic materials. The company offers scientific research reagents, such as PCR clone point mutation, nucleic acid extraction, reverse transcription, qPCR, cell/protein, gene editing series, and instant granules; high-throughput sequencing library construction reagents, including DNA and RNA library, single cell epigenetic, magnetic, quantitative series, and cell-free DNA storage and extractions; and biomedical reagents and services. It serves scientific research institutions, high-throughput sequencing service companies, molecular diagnostic reagent manufacturers, pharmaceutical companies, CRO companies, hospitals, and other medical institutions. The company was founded in 2012 and is based in Nanjing, China.

news impact assignment basic	general
public peers	general	Nov 20, 2024 7:38 PM	a88cef77
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 20, 2024 7:38 PM	b71355bb
crunchbase trigger	general	Nov 20, 2024 7:38 PM	e9650734
crunchbase profile	general	Nov 21, 2024 1:49 AM	bbb74bf4
li profile	general	Nov 20, 2024 7:38 PM	8bc54e5a
translate crunchbase fundingrounds	general	Nov 21, 2024 2:18 AM	c713389e
peers	general	Nov 20, 2024 7:38 PM	504d35cd
news basic	general	Nov 20, 2024 7:38 PM	8ceecc30
bundesanzeiger	filings
financials download nd	financials
private financials	financials

6881

COM:VAZYME

诺唯赞

Last Close

23.50

25/11 07:00

Market Cap

8.03B

Beta: -

Volume Today

2.19M

Avg: -